A CC-type chemokine with specificity for CCR7 RECEPTORS. It has activity towards T LYMPHOCYTES and B LYMPHOCYTES.
Chemokine Ccl19 has been studied across 18 research domains including 🛡️ Immunity, 🔬 Inflammation, 🔬 Oncology, 🫁 Respiratory, 🧬 Hormones. The primary research focus is 🛡️ Immunity with 29% of studies addressing this area.
This evidence profile for Chemokine Ccl19 is generated deterministically from 76 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.